A Retrospective Study On Liver Function Tests & Urine Protein in Presumptive Non-Alcoholic Fatty Liver Cases Performed in A Local Private Laboratory Service

Authors

  • Saiful Bahri Talip
  • Muhammad Hamdi Mahmood
  • Azam Hafizi Azmi Murad
  • Charisma Demai Edmand
  • Vimal Gengatharan
  • Yvonne Kar Kiat Ho

DOI:

https://doi.org/10.33736/tur.5118.2022

Keywords:

non-alcoholic fatty liver disease, aspartate-aminotransferase, alanine-aminotransferase, gamma-glutamyltransferase, urine protein, liver function test, renal function test

Abstract

Non-alcoholic fatty liver disease (NAFLD) could be diagnosed either by imaging or histology, and laboratory parameters from RFT such as AST, ALT, GGT, as well as UP. In this study, data were collected from Advanced Pathology Sdn. Bhd. The data collected from random population in the year of 2020 were used to identify the association between the parameters of AST, ALT, GGT and UP in presumed NAFLD patients, which are being compared by age, and gender. The results show that the level of GGT was having an insignificant association between gender (p >0.05), but there is a statistically significant association between the age group of respondents (p <0.05). In addition, results from AST indicated that the gender of respondents has a significant relationship with AST (p <0.05), however insignificant correlation between the age group (p >0.05). While for ALT, it proved an insignificant correlation between the gender of respondents (p >0.05), but significant correlated with the age of respondents (p <0.05). Lastly, Chi-square test independence gave a result of p-value = 0.137 (p >0.05), which proved insignificant correlation between gender of respondents and presence of UP andp-value = 0.261 (p >0.05), which proved insignificant correlation between age of respondents and presence of UP.        

(Chi-square test, p-value <0.05).  

 

 

Author Biographies

Saiful Bahri Talip

 

 

Muhammad Hamdi Mahmood

 

 

Azam Hafizi Azmi Murad

 

 

Charisma Demai Edmand

 

 

Vimal Gengatharan

 

 

Yvonne Kar Kiat Ho

 

 

References

Arshad, T., Golabi, P., Paik, J., Mishra, A., & Younossi, Z. M. (2018). Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population. Hepatology communications, 3(1), 74–83. https://doi.org/10.1002/hep4.1285

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.), 67(1), 328–357. https://doi.org/10.1002/hep.29367

Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012). The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology (Baltimore, Md.), 55(6), 2005–2023. https://doi.org/10.1002/hep.25762

Cobbina, E., Akhlaghi, F. (2017). Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug metabolism reviews, 49(2), 197–211. https://doi.org/10.1080/03602532.2017.1293683

Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011). Human fatty liver disease: old questions and new insights. Science (New York, N.Y.), 332(6037), 1519–1523. https://doi.org/10.1126/science.1204265

Dietrich, P., & Hellerbrand, C. (2014). Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best practice & research. Clinical gastroenterology, 28(4), 637–653. https://doi.org/10.1016/j.bpg.2014.07.008

Fan, R., Wang, J., Du, J. (2018). Association between body mass index and fatty liver risk: A dose-response analysis. Scientific reports 8. 15273. https://doi.org/10.1038/s41598-018-33419-6

Giannini, E. G., Testa, R., & Savarino, V. (2005). Liver enzyme alteration: a guide for clinicians. Canadian medical association journal, 172(3), 367–379. https://doi.org/10.1503/cmaj.1040752

Gutierrez-Grobe, Y., Ponciano-Rodríguez, G., Ramos, M. H., Uribe, M., & Méndez-Sánchez, N. (2010). Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Annals of hepatology, 9(4), 402–409.

Hashimoto, E., Taniai, M., & Tokushige, K. (2013). Characteristics and diagnosis of NAFLD/NASH. Journal of gastroenterology and hepatology, 28 Suppl 4, 64–70. https://doi.org/10.1111/jgh.12271

Hu, X. Y., Li, Y., Li, L. Q., Zheng, Y., Lv, J. H., Huang, S. C., Zhang, W., Liu, L., Zhao, L., Liu, Z., & Zhao, X. J. (2018). Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ open, 8(4), e019974. https://doi.org/10.1136/bmjopen-2017-019974

Lin, I. T., Lee, M. Y., Wang, C. W., Wu, D. W., & Chen, S. C. (2021). Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population. International journal of environmental research and public health, 18(3), 857. https://doi.org/10.3390/ijerph18030857

Ma, X., Liu, S., Zhang, J., Dong, M., Wang, Y., Wang, M., Xin, Y. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC gastroenterology, 20(1), 10. https://doi.org/10.1186/s12876-020-1165-z

Mehlig, K., Schult, A., Björkelund, C., Thelle, D., & Lissner, L. (2021). Associations between alcohol and liver enzymes are modified by coffee, cigarettes, and overweight in a Swedish female population. Scandinavian journal of gastroenterology, 57(3), 319–324. https://doi.org/10.1080/00365521.2021.2009557

Mitra, S., De, A., & Chowdhury, A. (2020). Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Translational gastroenterology and hepatology, 5, 16. https://doi.org/10.21037/tgh.2019.09.08

Nobili, V., Mantovani, A., Cianfarani, S., Alisi, A., Mosca, A., Sartorelli, M. R., Maffeis, C., Loomba, R., Byrne, C. D., Targher, G. (2019). Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. Journal of hepatology, 71(4), 802–810. https://doi.org/10.1016/j.jhep.2019.06.023

Parameswaran, M., Hasan, H. A., Sadeque, J., Jhaveri, S., Avanthika, C., Arisoyin, A. E., Dhanani, M. B., & Rath, S. M. (2021). Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus, 13(12), e20776. https://doi.org/10.7759/cureus.20776

Paschos, P., & Paletas, K. (2009). Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia- quarterly medical journal, 13(1), 9–19.

Ruhl, C. E., & Everhart, J. E. (2003). Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. American Gastroenterological Association, 124(1), 71–79. https://doi.org/10.1053/gast.2003.50004

Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015). Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 13(4), 643–e40. https://doi.org/10.1016/j.cgh.2014.04.014

Schuppan, D., & Afdhal, N. H. (2008). Liver cirrhosis. Lancet (London, England), 371(9615), 838–851. https://doi.org/10.1016/S0140-6736(08)60383-9

Sun, K., Lin, D., Li, F., Qi, Y., Feng, W., Yan, L., Chen, C., Ren, M., & Liu, D. (2018). Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China. BMJ open, 8(1), e019097. https://doi.org/10.1136/bmjopen-2017-019097

Tahan, V., Canbakan, B., Balci, H., Dane, F., Akin, H., Can, G., Hatemi, I., Olgac, V., Sonsuz, A., Ozbay, G., Yurdakul, I., & Senturk, H. (2008). Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepato-gastroenterology, 55(85), 1433–1438.

Ulasoglu, C., Enc, F. Y., Kaya, E., Yilmaz, Y. (2019). Characterization of patients with biopsy-proven Non-Alcoholic Fatty Liver Disease and normal Aminotransferase Levels. Journal of gastrointestinal and liver diseases: JGLD, 28(4), 427–431. https://doi.org/10.15403/jgld-293

Wong, T., Wong, R. J., Gish, R. G. (2019). Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Gastroenterology & hepatology, 15(2), 83–89.

Zhang, M., Lin, S., Wang, M. F., Huang, J. F., Liu, S. Y., Wu, S. M., Zhang, H. Y., Wu, Z. M., Liu, W. Y., Zhang, D. C., Hao, C. M., Zhu, Y. Y., Zheng, M. H., & Wang, X. Z. (2020). Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?. BMC gastroenterology, 20(1), 139. https://doi.org/10.1186/s12876-020-01278-z

Downloads

Published

2022-12-21

How to Cite

Talip, S. B., Mahmood, M. H. ., Azmi Murad, A. H. ., Edmand, C. D. ., Gengatharan , V. ., & Ho, Y. K. K. . . (2022). A Retrospective Study On Liver Function Tests & Urine Protein in Presumptive Non-Alcoholic Fatty Liver Cases Performed in A Local Private Laboratory Service . Trends in Undergraduate Research, 5(2), i1–8. https://doi.org/10.33736/tur.5118.2022

Issue

Section

Medicine and Health Sciences